Lonza Group AG LONN
Dividend Summary
The next Lonza Group AG dividend is expected to go ex in 6 months and to be paid in 6 months.
The previous Lonza Group AG dividend was 200c and it went ex 6 months ago and it was paid 6 months ago.
There is typically 1 dividend per year (excluding specials).
| Summary | Previous dividend | Next dividend |
|---|---|---|
| Status | Paid | Forecast |
| Type | Special | Final |
| Per share | 200c | Sign Up Required |
| Declaration date | 13 Feb 2024 (Tue) | 11 Feb 2025 (Tue) |
| Ex-div date | 13 May 2024 (Mon) | 12 May 2025 (Mon) |
| Pay date | 15 May 2024 (Wed) | 14 May 2025 (Wed) |
Enter the number of Lonza Group AG shares you hold and we'll calculate your dividend payments:
Sign up for Lonza Group AG and we'll email you the dividend information when they declare.
Add Lonza Group AG to receive free notifications when they declare their dividends.
Your account is set up to receive Lonza Group AG notifications.
| Status | Type | Decl. date | Ex-div date | Pay date | Decl. Currency | Forecast amount | Decl. amount | Accuracy |
|---|---|---|---|---|---|---|---|---|
| Forecast | Final | 06 Feb 2029 | 07 May 2029 | 09 May 2029 | CHF | Sign up | — | |
| Forecast | Final | 08 Feb 2028 | 08 May 2028 | 10 May 2028 | CHF | Sign up | — | |
| Forecast | Final | 09 Feb 2027 | 10 May 2027 | 12 May 2027 | CHF | Sign up | — | |
| Forecast | Special | 10 Feb 2026 | 11 May 2026 | 13 May 2026 | CHF | Sign up | — | |
| Forecast | Final | 10 Feb 2026 | 11 May 2026 | 13 May 2026 | CHF | Sign up | — | |
| Forecast | Special | 11 Feb 2025 | 12 May 2025 | 14 May 2025 | CHF | Sign up | — | |
| Forecast | Final | 11 Feb 2025 | 12 May 2025 | 14 May 2025 | CHF | Sign up | — | |
| Paid | Special | 13 Feb 2024 | 13 May 2024 | 15 May 2024 | CHF | — | 200c | |
| Paid | Final | 13 Feb 2024 | 13 May 2024 | 15 May 2024 | CHF | 350c | 200c | 😖 |
| Paid | Special | 26 Jan 2023 | 09 May 2023 | 11 May 2023 | CHF | — | 175c | |
| Paid | Final | 25 Jan 2023 | 09 May 2023 | 11 May 2023 | CHF | 285c | 175c | 😓 |
| Paid | Special | 26 Jan 2022 | 09 May 2022 | 11 May 2022 | CHF | — | 150c | |
| Paid | Final | – | 09 May 2022 | 11 May 2022 | CHF | 275c | 150c | 😖 |
| Paid | Special | 27 Jan 2021 | 10 May 2021 | 12 May 2021 | CHF | — | 150c | |
| Paid | Final | 27 Jan 2021 | 10 May 2021 | 12 May 2021 | CHF | — | 150c | |
| Paid | Special | 21 Jan 2020 | 30 Apr 2020 | 05 May 2020 | CHF | — | 275c | |
| Paid | Special | 30 Jan 2019 | 24 Apr 2019 | 26 Apr 2019 | CHF | — | 275c | |
| Paid | Special | 31 Jan 2018 | 08 May 2018 | 11 May 2018 | CHF | — | 275c | |
| Paid | Final | 30 Mar 2017 | 27 Apr 2017 | 03 May 2017 | CHF | — | 275c | |
| Paid | Final | 16 Mar 2016 | 26 Apr 2016 | 28 Apr 2016 | CHF | — | 250c | |
| Paid | Final | 04 Mar 2015 | 10 Apr 2015 | 14 Apr 2015 | CHF | — | 250c | |
| Paid | Final | 23 Jan 2014 | 22 Apr 2014 | 25 Apr 2014 | CHF | — | 215c | |
| Paid | Final | 24 Jan 2013 | 11 Apr 2013 | 16 Apr 2013 | CHF | — | 215c |
| Year | Amount | Change |
|---|---|---|
| 2006 | 0.0c | — |
| 2007 | 0.0c | 0% |
| 2008 | 0.0c | 0% |
| 2009 | 0.0c | 0% |
| 2010 | 0.0c | 0% |
| 2011 | 0.0c | 0% |
| 2012 | 215.0c | 100% |
| 2013 | 215.0c | 0% |
| 2014 | 250.0c | 16.3% |
| 2015 | 250.0c | 0% |
| 2016 | 275.0c | 10.0% |
| 2017 | 0.0c | -100.0% |
| 2018 | 0.0c | 0% |
| 2019 | 0.0c | 0% |
| 2020 | 0.0c | 0% |
| 2021 | 150.0c | 100% |
| 2022 | 150.0c | 0% |
| 2023 | 175.0c | 16.7% |
| 2024 | Sign Up Required | |
| 2025 | Sign Up Required | |
| 2026 | Sign Up Required | |
| 2027 | Sign Up Required | |
| 2028 | Sign Up Required | |
| 2029 | Sign Up Required | |
Lonza Group AG Optimized Dividend Chart
- Dividend Yield Today
- 0.4%
- Optimized Yield
- Sign Up Required
- 52 Week High
- 1.5% on 11 December 2023
- 52 Week Low
- 0.5% on 31 July 2024
- Next Ex-Div-Date Countdown
- Sign Up Required
About Lonza Group AG
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.
- Sector
- Pharmaceuticals & Biotechnology
- Country
- Switzerland
- Share Price
- Fr.523.00 (yesterday's closing price)
- Shares in Issue
- 72 million
- Market Cap
- Fr.37.8bn
- 2
- Market Indices
- STOXX600
